Accession Number: | 0001735276-20-000064 |
Date: | 2020-06-22 |
Issuer: | ALNYLAM PHARMACEUTICALS, INC. (ALNY) |
Original Submission Date: |
VAISHNAW AKSHAY
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-06-22 | M | 970 | a | $42.22 | 15,089 | direct | ||
COMMON STOCK | 2020-06-22 | S | 178 | d | $148.48 | 14,911 | direct | ||
COMMON STOCK | 2020-06-22 | S | 83 | d | $149.09 | 14,828 | direct | ||
COMMON STOCK | 2020-06-22 | S | 180 | d | $150.34 | 14,648 | direct | ||
COMMON STOCK | 2020-06-22 | S | 334 | d | $152.22 | 14,314 | direct | ||
COMMON STOCK | 2020-06-22 | S | 195 | d | $152.97 | 14,119 | direct | ||
COMMON STOCK | 2020-06-22 | 0 | $0.00 | 515 | indirect | f7 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 42.22 | 2020-06-22 | deemed execution date | M | 970 (d) | 2026-12-20 | common stock 970 | $42.22 | 4,309 | direct |
ID | footnote |
---|---|
f1 | all sales reported on this form 4 were made pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 04, 2019. |
f2 | sale prices ranged from $148.01 to $148.78. |
f3 | sale prices ranged from $149.07 to $149.96. |
f4 | sale prices ranged from $150.18 to $150.53. |
f5 | sale prices ranged from $151.58 to $152.56. |
f6 | sale prices ranged from $152.84 to $153.34. |
f7 | reflects shares of alny common stock acquired by the reporting person under the alny 401(k) plan as a result of the alny 401(k) matching contribution program. |
f8 | the stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. |